Medical Marijuana Reduces Pain, Improves Sleep and Anxiety in Women With Endometriosis While Cutting Opioid Use

A new study demonstrates that cannabis-based medicinal products (CBMPs) provide sustained improvements in pain, sleep, anxiety, and quality of life for women with endometriosis over 24 months. The research shows that medical marijuana was well-tolerated by most patients and significantly reduced their reliance on opioid medications. This finding is particularly significant as endometriosis affects millions of women worldwide and often requires long-term pain management. The ability of cannabis to address multiple symptoms simultaneously while decreasing opioid dependency offers patients a potentially safer therapeutic alternative with fewer risks of addiction and overdose.